普罗帕酮
首过效应
普萘洛尔
药物代谢
药代动力学
维拉帕米
利多卡因
药理学
药品
新陈代谢
医学
第一次通过
内科学
麻醉
数学
钙
心房颤动
算术
作者
David Lalka,Robert K. Griffith,Carol Cronenberger
标识
DOI:10.1002/j.1552-4604.1993.tb04720.x
摘要
The first-pass hepatic metabolism of a number of important therapeutic agents is inconsistent with traditional models that assume that the hepatic extraction ratio of a drug is constant in each individual (independent of the concentration of drug in the hepatic sinusoidal blood and also independent of the history of exposure to the drug). In this review, the authors examine the first-pass metabolism of five "problematic drugs" (propranolol, lidocaine, propafenone, verapamil, and nitroglycerin). Each of these compounds has unique facets to its hepatic clearance and pharmacokinetics as well as striking similarities. Selected aspects of first-pass metabolism are reviewed, and a theory that may explain some of the unusual behavior of the four lipophilic bases (propranolol, lidocaine, propafenone, and verapamil) is presented. Finally, the unusual and variable clearance of nitroglycerin is discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI